IRIS
FRIERI, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.985
EU - Europa 1.977
AS - Asia 1.333
SA - Sud America 112
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AF - Africa 2
Totale 6.421
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.972
IE - Irlanda 576
CN - Cina 457
SG - Singapore 380
SE - Svezia 301
TR - Turchia 269
RU - Federazione Russa 205
DE - Germania 203
HK - Hong Kong 173
IT - Italia 163
UA - Ucraina 162
GB - Regno Unito 157
BR - Brasile 98
FI - Finlandia 78
FR - Francia 68
BE - Belgio 21
CZ - Repubblica Ceca 17
VN - Vietnam 13
IN - India 12
NL - Olanda 10
CA - Canada 9
AR - Argentina 7
EU - Europa 6
AU - Australia 5
JP - Giappone 5
EC - Ecuador 4
EE - Estonia 3
IL - Israele 3
JO - Giordania 3
RO - Romania 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
HR - Croazia 2
IQ - Iraq 2
LT - Lituania 2
LU - Lussemburgo 2
NP - Nepal 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BM - Bermuda 1
BO - Bolivia 1
BT - Bhutan 1
CR - Costa Rica 1
GE - Georgia 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
KE - Kenya 1
LB - Libano 1
MX - Messico 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
SA - Arabia Saudita 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 6.421
Salva come PNG Salva come JPEG
Città #
Jacksonville 646
Chandler 614
Dublin 576
Boardman 191
Singapore 180
Hong Kong 173
Santa Clara 173
Izmir 135
Nanjing 135
Ann Arbor 110
San Mateo 108
New York 91
Lawrence 84
Princeton 84
Wilmington 72
Beijing 60
Ashburn 56
Moscow 53
Milan 42
Woodbridge 39
L'aquila 33
Dearborn 31
Nanchang 31
Verona 24
Des Moines 23
Shenyang 23
Brussels 21
Kunming 21
Shanghai 21
Bremen 20
Tianjin 20
Seattle 19
Hebei 18
Brno 17
Jiaxing 17
Jinan 16
Norwalk 15
Mountain View 13
Dong Ket 12
L’Aquila 12
Ningbo 11
Changsha 10
Council Bluffs 10
Helsinki 10
São Paulo 10
Hangzhou 9
London 9
Rome 9
Los Angeles 8
Munich 8
Amsterdam 7
Auburn Hills 7
Falls Church 6
Hefei 6
Tappahannock 6
Zhengzhou 6
Berlin 5
Falkenstein 5
Guangzhou 5
Taizhou 5
Changchun 4
Dallas 4
Lanzhou 4
Philadelphia 4
Pune 4
Stockholm 4
Amman 3
Brasília 3
Chicago 3
Edinburgh 3
Fairfield 3
Fremont 3
Napoli 3
Ottawa 3
Phoenix 3
Quito 3
Redmond 3
Ribeirão Preto 3
Rio de Janeiro 3
Sydney 3
Tallinn 3
Tashkent 3
The Dalles 3
Baku 2
Belo Horizonte 2
Borgaro Torinese 2
Brindisi 2
Caraguatatuba 2
Chongqing 2
Curitiba 2
Frankfurt am Main 2
Fátima do Sul 2
Gonzales 2
Harbin 2
New Delhi 2
Prata 2
San Francisco 2
Seguin 2
Tokyo 2
Vila Velha 2
Totale 4.290
Salva come PNG Salva come JPEG
Nome #
Association between vasomotor rhinitis and irritable bowel syndrome. 151
Association between colonic diverticula and colorectal polyps and cancer 125
Subtypes of chronic gastritis in patients with coeliac disease before and after gluten-free diet 121
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms 120
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet 119
Lymphocytic gastritis is present in Celiac Disease and improves after gluten-free diet. 112
Association between colorectal polyps and colonic diverticulosis 110
Histological healing in ulcerative colitis with mesalazine and its prognostic role 103
IgG4-Related Disease Mimicking Crohn's Disease: A Case Report and Review of Literature 97
Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin? 95
Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet 90
Ulcerative Colitis: rectal dilations in a patient with refractory diarrhoea. Report of a case 86
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 86
Effects of bombesin and bombesin-like peptides on gastrointestinal myoelectric activity 85
Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats 84
Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's Disease: a GISC study 84
Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-β1 downregulation 83
Advances in the pathogenesis of inflammatory bowel diseases: Capri 2010 82
Italian Group for the Study of the Colon and Rectum: Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study 82
Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis. 82
Short-chain fatty acids topical treatment in distal ulcerative colitis 81
Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients 80
Electrolyte and acid base imbalance in patients with rectosigmoid bladder. 80
Early acid perception in NERD 80
Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea 80
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine 80
Colonic electromyography in chronic constipation. 79
Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet 79
Colonoscopic control of uretero-enteric anastomoses in internal urinary diversion. 78
Dextran sulfate sodium (DSS) colitis in rats. Clinical, structural, and ultrastructual aspects 78
Prognostic factors for post-operative recurrence of Crohn's disease 78
Mucosal healing: Mayo 0 vs 1 after 3 years. 78
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine 77
Acute colitis following colonoscopy 77
GI distension in severe ulcerative colitis 77
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of postoperative recurrence of Crohn's disease 77
Assesment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhancement MRI 76
n-Butyrate Rectal Transport in Cirrhotic Patients 76
Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis Randomized, Double-Blind, Placebo-Controlled Pilot Study 75
Carbonic andhydrase I reduction in colonic mucosa of patients with active ulcerative colitis 75
Is fecal calprotectin an accurate marker in the management of Crohn's disease? 75
Multiple organ dysfunction in ulcerative colitis 74
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 74
Management of colonic diverticular disease. 74
Report of the 3rd National Congress of the Italian Federation of Coloproctology. 73
An unusual treatment for a colonic polyp. 72
Abnormal Patterns of Colonic Mucin Secretion after Ureterosigmoidostomy 72
Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopic biopsy samples in humans by high-performance liquid chromatography with electrochemical detection 72
Lactose malabsorption and irritable bowel syndrome. Effect of a long-term lactose-free diet. 71
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. 71
Incidence of inflammatory Bowel disease in Italy: A nationwide population-based study 71
Gastrointestinal: Eosinophilic ascites. 71
Sleep disorders related to nutrition and digestive diseases: A neglected clinical condition 71
CROHN’S DISEASE ACTIVITY INDEX IS INACCURATE TO DETECT THE POSTOPERATIVE RECURRENVCE IN CROHN’S DISEASE 70
Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment 69
Abnormal Patterns of Colorectal Mucin Secretion after Urinary Diversion of Different Types: Histochemical and Lectin Binding Studies 69
Abnormalities of colonic mucin secretion and metabolic changes after internal urinary diversion for bladder extrophy. A prospective study. 69
Can Nrf2 modulate the development of intestinal fibrosis and cancer in inflammatory bowel disease? 69
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations 68
Current opinions on treatment of inflammatory bowel disease 68
Consequence of colonic involvement on electrolyte and acid-base homeostasis in crohn's disease 68
Mucosal 5-ASA concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis 68
Duodenal lymphocytosis in functional dyspepsia 68
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis? 68
Inflammatory bowel disease: New insights into the interplay between environmental factors and pparγ 66
Italian consensus guidelines for chronic pancreatitis. 65
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis 65
Is mesalazine treatment effective in the prevention of diverticulitis? A review 65
Treatment of inflammatory bowel diseases: To heal the wound or to heal the sick? 64
Il 5-ASA (Asacol) previene le recidive post-operatorie del morbo di Crohn. Risultati dello studio GISC a tre anni di follow-up. 64
Risk factors in toxic megacolon 63
Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis 63
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 62
Historical evolution of the management of severe ulcerative colitis 61
Mesalazine vanishing time from rectal mucosa following its topical administration. 61
Celiac disease, gluten-free diet, and metabolic and liver disorders 61
Association between corrected QT interval and C-reactive protein in patients with inflammatory bowel diseases 61
Meccanismi e approccio alla fisiopatologia della diarrea. 58
The long journey of salicylates in ulcerative colitis: The past and the future. 57
The dyspeptic macrophage 30 years later. An update in the pathogenesis of Crohn's disease 54
The role on endoscopy in alcohol-related diseases 54
Genetic analysis in italian families with inflammatory bowel disease supports linkage to the IBD1 locus-a GISC study 53
Fattori di rischio per la recidiva post-operatoria nel morbo di Crohn. 53
Faecal excretion of bicarbonate in ulcerative colitis 52
Thecnical performance of colonoscopy: thekey role of sedation/analgesia and other quality indicators 46
Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn's Patients 23
Totale 6.524
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.716
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020116 0 0 0 0 0 0 0 0 0 26 6 84
2020/2021767 17 94 3 106 86 29 102 8 91 36 151 44
2021/2022566 37 49 129 44 23 4 10 31 25 28 37 149
2022/20231.714 116 97 30 197 152 186 0 116 740 7 47 26
2023/2024390 56 22 17 60 27 112 21 18 0 9 5 43
2024/20251.255 18 25 145 36 150 130 228 163 344 16 0 0
Totale 6.524